Human monoclonal antibodies to neutralize all dengue virus serotypes using lymphocytes from patients at acute phase of the secondary infection

Biochemical and Biophysical Research Communications

Volumn 423, Issue 4, 2012, Pages 867-872

  Setthapramote, Chayanee ^a,g   Sasaki, Tadahiro ^b,g   Puiprom, Orapim ^c   Limkittikul, Kriengsak ^c,g   Pitaksajjakul, Pannamthip ^c,g   Pipattanaboon, Chonlatip ^a,g   Sasayama, Mikiko ^c   Leuangwutiwong, Pornsawan ^a,g   Phumratanaprapin, Weerapong ^c,g   Chamnachanan, Supat ^c,g   Kusolsuk, Teera ^c,g   Jittmittraphap, Akanitt ^a,g   Asai, Azusa ^b,g   Arias, Juan Fernando ^b,g   Hirai, Itaru ^d,g   Kuhara, Motoki ^e,g   Okuno, Yoshinobu ^f   Kurosu, Takeshi ^b,c,g   Ramasoota, Pongrama ^c,g   Ikuta, Kazuyoshi ^b,c,g  

^a MAHIDOL UNIVERSITY   (Thailand)

^b OSAKA UNIVERSITY   (Japan)

^c MAHIDOL UNIVERSITY   (Thailand)

^d OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e Medical & Biological Laboratories Co Ltd   (Japan)

^f OSAKA UNIVERSITY   (Japan)

^g JAPAN INTERNATIONAL COOPERATION AGENCY   (Japan)

Author keywords

Acute phase; Dengue virus; Human monoclonal antibodies; Peripheral blood mononuclear cell; Secondary infection

Indexed keywords

MONOCLONAL ANTIBODY; VIRUS PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; CROSS REACTION; DENGUE; DENGUE VIRUS; FEMALE; HUMAN; HUMAN CELL; HYBRIDOMA; IMMUNOFLUORESCENCE; LYMPHOCYTE; MALE; MEMORY CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMA CELL; PRIORITY JOURNAL; SECONDARY INFECTION; SEROTYPE; VIRUS NEUTRALIZATION;

ADULT; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; CERCOPITHECUS AETHIOPS; COINFECTION; DENGUE; DENGUE VIRUS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; HYBRIDOMAS; LYMPHOCYTES; MALE; NEUTRALIZATION TESTS; SEROTYPING; VERO CELLS; VIRAL PROTEINS; YOUNG ADULT;

DENGUE VIRUS;

EID: 84863824167     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.06.057     Document Type: Article

References (20)

1. Kuhn R.J., Zhang W., Rossmann M.G., Platnev S.V., Corver J., Lenches E., Jones C.T., Mukhopadhyay S., Chipman P.R., Strause E.G., Baker T.S., Strauss J.H. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 2002, 108:717-725.
2. TJ Braciale, YS Hahn, DR Burton, The adaptive immune response to viruses, in: D.M. Knipe, P.M. Howley, D.E. Griffin, R.A. Lamb (Eds.), Fields Virology, fifth ed., Lippincott Williams & Wilkins, 2006, pp. 279-325.
3. van der Schaar H.M., Wilschut J.C., Smit J.M. Role of antibodies in controlling dengue virus infection. Immunobiology 2009, 214:613-629.
4. Sangkawibha N., Rojanasuphot S., Ahandrik S., Viriyapongse S., Jatanasen S., Salitul V., Phanthumachinda B., Halstead SB. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am. J. Epidemiol. 1980, 120(1984):653-669.
5. Halstead S.B., O'Rourke E.J. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J. Exp. Med. 1977, 146:201-217.
6. Diamond M.S., Pierson T.C., Fremont D.H. The structural immunology of antibody protection against West Nile virus. Immunol. Rev. 2008, 225:212-225.
7. Reiter P. Yellow fever and dengue: a threat to Europe?. EuroSurveillance 2010, 15:19509.
8. García G., Sierra B., Pérez A.B., Aguirre E., Rosado I., Gonzalez N., Izquierdo A., Pupo M., Díaz D.R.D., Sánchez L., Marcheco B., Hirayama K., Guzmán M.G. Asymptomatic dengue infection in a Cuban population confirms the protective role of the RR variant of the FcγRIIa polymorphism. Am. J. Trop. Med. Hyg. 2010, 82:1153-1156.
9. Harris E., Videa E., Perez L., Sandoval E., Tellez Y., Perez M.L., Cuadra R., Rocha J., Idiaquez W., Alonso R.E., Delgado M.A., Campo L.A., Acevedo F., Gonzalez A., Amador J.J., Balmaseda A. Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in Nicaragua. Am. J. Trop. Med. Hyg. 1998, 63(2000):5-11.
10. Kubota-Koketsu R., Mizuta H., Oshita M., Ideno S., Yunoki M., Kuhara M., Yamamoto N., Okuno Y., Ikuta K. Broad neutralizing human monoclonal antibodies against influenza virus from vaccinated healthy donors. Biochem. Biophys. Res. Commun. 2009, 387:180-185.
11. Kurosu T., Khamlert C., Phanthanawiboon S., Ikuta K., Anatapreecha S. Highly efficient rescue of dengue virus using a co-culture system with mosquito/mammalian cells. Biochem. Biophys. Res. Commun. 2010, 394:398-404.
12. Yenchitsomanus P., Sricharoen P., Jaruthasana I., Pattanakitsakul S., Nitayaphan S., Mongkolsapaya J., Malasit P. Rapid detection and identification of dengue viruses by polymerase chain reaction (PCR), Southeast Asian. J.Trop. Med. Public Health 1996, 27:228-236.
13. Falconar A.K.I. Identification of an epitope on the dengue virus membrane (M) protein defined by cross-protective monoclonal antibodies: design of an improved epitope sequence based on common determinants present in both envelope (E and M) proteins. Arch. Virol. 1999, 144:2313-2330.
14. Okuno Y., Igarashi A., Fukai K. Neutralization tests for dengue and Japanese encephalitis viruses by the focus reduction method using peroxidase-anti-peroxidase staining. Biken J. 1978, 21:137-147.
15. Kurosu T., Chaichana P., Yamate M., Anantapreecha S., Ikuta K. Secreted complement regulatory protein clusterin interacts with dengue virus nonstructural protein 1. Biochem. Biophys. Res. Commun. 2007, 362:1051-1056.
16. Dejnirattisai W., Jumnainsong A., Onsirisakul N., Fitton P., Vasanawathana S., Limpitikul W., Puttikhunt C., Edwards C., Duangchinda T., Supasa S., Chawansuntati K., Malasit P., Mongkolsapaya J., Screaton G. Cross-reacting antibodies enhance dengue virus infection in humans. Science 2010, 328:745-748.
17. Beltramello M., Williams K.L., Simmons C.P., Macagno A., Simonelli L., Quyen N.T., Sukupolvi-Petty S., Navarro-Sanchez E., Young P.R., de Silva A.M., Rey F.A., Varani L., Whitegead S.S., Diamond M.S., Harris E., Lanzavecchia A., Sallusto F. The human immune response to dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. Cell Host Microbe 2010, 8:271-283.
18. de Alwis R., Beltramello M., Messer W.B., Sukupolvi-Petty S., Wahala W.M.P.B., Kraus A., Olivarez N.P., Pham Q., Brian J., Tsai W.-Y., Wang W.-K., Halstead S., Kliks S., Diamond M.S., Baric R., Lanzavecchia A., Sallusto F., de Silva A.M. In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection. PLoS Negl. Trop. Dis. 2011, 5:e1188.
19. Wrammert J., Smith K., Miller J., Langley W.A., Kokko K., Larsen C., Zheng N.-Y., Mays I., Garman L., Helms C., James J., Air G.M., Capra J.D., Ahmed R., Wilson P.C. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 2008, 453:667-671.
20. Leyendeckers H., Odendahl M., Löhndorf A., Irsch J., Spangfort M., Miltenyi S., Hunzelmann N., Assenmacher M., Radbruch A., Schmitz J. Correlation analysis between frequencies of circulating antigen-specific IgG-bearing memory B cells and serum titers of antigen-specific IgG. Eur. J. Immunol. 1999, 29:1406-1417.